Androgen_NN
binding_NN
sites_NNS
in_IN
peripheral_JJ
human_JJ
mononuclear_JJ
leukocytes_NNS
of_IN
healthy_JJ
males_NNS
and_CC
females_NNS
._.

Androgen_NN
binding_NN
sites_NNS
have_VBP
been_VBN
identified_VBN
in_IN
circulating_VBG
human_JJ
mononuclear_JJ
leukocytes_NNS
of_IN
healthy_JJ
donors_NNS
of_IN
both_DT
sexes_NNS
._.

Cells_NNS
were_VBD
separated_VBN
from_IN
blood_NN
samples_NNS
on_IN
a_DT
Ficoll_NN
gradient_NN
and_CC
incubated_VBN
with_IN
different_JJ
concentrations_NNS
of_IN
-LCB-_-LRB-
3H-RCB-testosterone_NN
in_IN
the_DT
presence_NN
or_CC
absence_NN
of_IN
a_DT
400-fold_JJ
excess_NN
of_IN
unlabelled_JJ
testosterone_NN
._.

Binding_NN
data_NNS
were_VBD
derived_VBN
from_IN
Scatchard_NN
analysis_NN
._.

The_DT
binding_VBG
sites_NNS
fulfil_VBP
the_DT
required_JJ
criteria_NNS
for_IN
specific_JJ
steroid_NN
binding_NN
sites_NNS
however_RB
differ_VB
somewhat_RB
from_IN
the_DT
classic_JJ
androgen_NN
receptors_NNS
from_IN
genital_JJ
skin_NN
fibroblast_NN
:_:
in_IN
fertile_JJ
adult_JJ
males_NNS
-LRB-_-LRB-
n_NN
=_JJ
20_CD
-RRB-_-RRB-
the_DT
binding_VBG
sites_NNS
showed_VBD
-LRB-_-LRB-
1_LS
-RRB-_-RRB-
a_DT
high_JJ
affinity_NN
for_IN
testosterone_NN
-LRB-_-LRB-
1.32_CD
+_CC
\/_CD
-_:
0.49_CD
nM_NN
;_:
mean_NN
+_CC
\/_NN
-_TO
SD_NN
-RRB-_-RRB-
,_,
-LRB-_-LRB-
2_LS
-RRB-_-RRB-
a_DT
saturable_JJ
capacity_NN
-LRB-_-LRB-
184_CD
+_CC
\/_JJ
-_:
52_CD
binding_NN
sites_NNS
per_IN
cell_NN
;_:
mean_NN
+_CC
\/_NN
-_TO
SD_NN
-RRB-_-RRB-
,_,
and_CC
-LRB-_-LRB-
3_LS
-RRB-_-RRB-
a_DT
characteristic_JJ
competitive_JJ
binding_NN
profile_NN
for_IN
other_JJ
steroid_NN
hormones_NNS
-LRB-_-LRB-
relative_JJ
binding_NN
affinities_NNS
:_:
testosterone_NN
=_JJ
dihydrotestosterone_NN
&gt;_JJR
17_CD
beta-estradiol_NN
&gt;_JJR
progesterone_NN
,_,
whereas_IN
aldosterone_NN
,_,
17-hydroxy-progesterone_NN
and_CC
cortisol_NN
did_VBD
not_RB
compete_VB
appreciably_RB
-RRB-_-RRB-
._.

Furthermore_RB
the_DT
number_NN
of_IN
binding_VBG
sites_NNS
determined_VBN
using_VBG
-LCB-_-LRB-
3H-RCB-dihydrotestosterone_NN
,_,
-LCB-_-LRB-
3H-RCB-RU-1881_CD
,_,
or_CC
-LCB-_-LRB-
3H-RCB-testosterone_NN
were_VBD
comparable_JJ
._.

This_DT
raises_VBZ
the_DT
possibility_NN
that_IN
androgen_NN
receptors_NNS
in_IN
peripheral_JJ
mononuclear_JJ
leukocytes_NNS
differ_VBP
from_IN
those_DT
in_IN
genital_JJ
skin_NN
fibroblasts_NNS
._.

There_EX
was_VBD
no_DT
apparent_JJ
correlation_NN
between_IN
serum_NN
testosterone_NN
concentrations_NNS
and_CC
androgen_NN
binding_NN
sites_NNS
._.

In_IN
fertile_JJ
women_NNS
remarkable_JJ
changes_NNS
in_IN
androgen_NN
binding_NN
sites_NNS
were_VBD
seen_VBN
in_IN
the_DT
course_NN
of_IN
the_DT
menstrual_JJ
cycle_NN
,_,
with_IN
a_DT
significant_JJ
increase_NN
in_IN
the_DT
immediate_JJ
preovulatory_JJ
period_NN
._.

The_DT
presence_NN
of_IN
androgen_NN
receptors_NNS
in_IN
peripheral_JJ
mononuclear_JJ
leukocytes_NNS
provides_VBZ
for_IN
the_DT
first_JJ
time_NN
the_DT
experimental_JJ
basis_NN
for_IN
an_DT
hypothesis_NN
of_IN
direct_JJ
,_,
receptor-mediated_JJ
effects_NNS
of_IN
androgens_NNS
on_IN
mature_JJ
immunocompetent_JJ
cells_NNS
._.

The_DT
immunological_JJ
implications_NNS
of_IN
these_DT
results_NNS
are_VBP
discussed_VBN
._.

